Current therapy for Langerhans cell histiocytosis

Hematology/Oncology Clinics of North America

Volumn 12, Issue 2, 1998, Pages 327-338

  Broadbent, V ^a   Gadner, H ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLADRIBINE; CYCLOSPORIN A; ETOPOSIDE; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; PREDNISOLONE; VINBLASTINE;

CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIABETES INSIPIDUS; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DRUG CHOICE; DRUG EFFICACY; HISTIOCYTOSIS X; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW;

EID: 0031947898     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70513-X     Document Type: Article

References (40)

1. R.P. Aronson Streptomycin in Letterer-Siwe disease Lancet 1 1951 889
2. V. Broadbent J. Pritchard Diabetes insipidus associated with Langerhans cell histiocytosis: Is it reversible? Med Pediatr Oncol 28 1997 289 293
3. V. Broadbent H. Gadner D.M. Komp S. Ladisch Histiocytosis syndromes in children II. Approach to complete clinical and laboratory evaluation of children with Langerhans cell histiocytosis Med Pediatr Oncol 17 1989 492 495
4. V. Broadbent J. Pritchard E. Yeomans Etoposide (VP 16) in the treatment of multisystem Langerhans cell histiocytosis (histiocytosis X) Med Pediatr Oncol 17 1989 97 100
5. V. Broadbent D.B. Dunger E. Yeomans B. Kendall Anterior pituitary function and CT/MR imaging in patients with Langerhans cell histiocytosis and diabetes insipidus Med Pediatr Oncol 21 1993 31 35
6. A. Ceci M. de Terlizzi R. Colella Langerhans cell histiocytosis in childhood: Results from the Italian Cooperative AIEOP-CNR-HX 83 study Med Pediatr Oncol 21 1993 265 270
7. A. Chu G.J. D'Angio B. Favara Histiocytosis syndromes in children Lancet 8526 1987 208 209
8. E.G. Davies R.J. Levinsky M. Butler Thymic hormone therapy for histiocytosis X N Engl J Med 309 1983 493 494
9. D.B. Dunger V. Broadbent E. Yeomans The frequency and natural history of diabetes insipidus in children with Langerhans cell histiocytosis N Engl J Med 321 1989 157 162
10. R.M. Egeler R.C. Thompson P.A. Voute M.E. Nesbit Intralesional infiltration of corticosteroids in localised Langerhans cell histiocytosis J Pediatr Orthop 12 1992 811 814
11. H. Gadner A. Heitger N. Grois Treatment strategy for disseminated Langerhans cell histiocytosis Med Pediatr Oncol 23 1994 72 80
12. J.S. Greenberger A.C. Crocker G. Vawter Results of treatment of 127 patients with systemic histiocytosis Medicine 60 1986 331 338
13. N. Grois B. Fulcher-Wolfram A. Heitger Diabetes insipidus in Langerhans cell histiocytosis: Results from the DAL-HX 83 study Med Pediatr Oncol 24 1995 248 256
14. G. Kannaourakis A. Abbas The role of cytokines in the pathogenesis of Langerhans cell histiocytosis Br J Cancer 70 suppl XXIII 1994 S37 S40
15. K.M. Kelly J. Pritchard Monoclonal antibody therapy in Langerhans cell histiocytosis—feasible or reasonable? Br J Cancer 70 suppl XXIII 1994 S54 S55
16. D.M. Komp A. El Mahdi K.A. Starling Quality of survival in histiocytosis X: A Southwest Oncology Group study Med Pediatr Oncol 8 1980 35 40
17. D.M. Komp T.J. Vietti D.H. Berry Combination chemotherapy in Histiocytosis X Med Pediatr Oncol 3 1977 267 273
18. S. Ladisch H. Gadner M. Arico LCH 1: A randomised trial of etoposide versus vinblastine in disseminated Langerhans cell histiocytosis Med Pediatr Oncol 23 1994 107 110
19. M.E. Lahey Histiocytosis X—comparison of three treatment regimes J Pediatr 87 1975 179 183
20. M.E. Lahey Histiocytosis X: An analysis of prognostic factors J Pediatr 87 1975 184 189
21. Mahmoud H, Broadbent V. Results of the Histiocyte Society cyclosporine salvage therapy questionnaire. Proc 9th Annual Meeting Histiocyte Society, 1993.
22. H. Mahmoud W. Wang S. Murphy Cyclosporine therapy for advanced Langerhans cell histiocytosis Blood 77 1991 721 725
23. G. McCowage D. Frush J. Kurtzberg Successful treatment of two children with Langerhans cell histiocytosis with 2′-deoxycofomycin Am J Pediatr Hematol Oncol 18 1996 154 158
24. J. McLelland V. Broadbent E. Yeomans Langerhans cell histiocytosis: A conservative approach to treatment Arch Dis Child 65 1990 301 303
25. K.J. Minehan M.G. Chen D. Zimmermann Radiation therapy for diabetes insipidus caused by Langerhans cell histiocytosis Int J Radiol Oncol Biol Phys 23 1992 519 524
26. G. Morgan Myeloablative therapy and bone marrow transplantation for Langerhans cell histiocytosis Br J Cancer 70 suppl XXIII 1994 S52 S53
27. Oliver L, Munn S, Broadbent V, et al. Indomethacin—a useful “adjunctive” therapy in Langerhans cell histiocytosis. Experience at Great Ormond Street Hospital, London 1984–1995. Proc Histiocyte Society 12th Annual Meeting, 1996.
28. M.E. Osband J.M. Lipton P. Lavin Histiocytosis X: Demonstration of abnormal immunity, T-cell histamine H2-receptor deficiency and successful treatment with thymic extract N Engl J Med 304 1981 146 153
29. L.D. Piro 2-Chlorodeoxyadenosine treatment of lymphoid malignancies Blood 79 1992 843 845
30. R.B. Raney G.J. D'Angio Langerhans cell histiocytosis (histiocytosis X): Experience at the Children's Hospital of Philadelphia 1970–1984 Med Pediatr Oncol 17 1989 20 28
31. R.J. Risdall L.P. Dehner P. Duran Histiocytosis X (Langerhans cell histiocytosis): Prognostic role of histopathology Arch Pathol Lab Med 107 1983 59 63
32. K.E. Rosenzweig R.J. Arceci N.J. Tarbell Diabetes insipidus secondary to Langerhans cell histiocytosis: Is radiation therapy indicated? Med Pediatr Oncol 29 1997 36 40
33. S.H. Sacks I. Hall N. Ragge J. Pritchard Chronic dermal sinuses as a manifestation of histiocytosis X Br Med J 292 1986 1097 1098
34. Saven A, Foon KA, Piro LD. 2-Chlorodeoxyadenosine-induced complete remissions in Langerhans cell histiocytosis. Proc Histiocyte Society 10th Annual Meeting, 1994.
35. M.P. Sheehan D.J. Atherton V. Broadbent Topical nitrogen mustard: An effective treatment for cutaneous Langerhans cell histiocytosis J Pediatr 119 1991 317 321
36. D.G. Sims Histiocytosis X: Follow up of 43 cases Arch Dis Child 52 1977 433 440
37. K.A. Starling M.H. Donaldson M.E. Haggard Therapy of histiocytosis X with vincristine, vinblastine and cyclophosphamide Am J Dis Child 123 1972 105 110
38. I.R.G. Toogood W.M. Ellis H. Ekert Prognostic criteria, treatment and survival in disseminated histiocytosis X Aust Paediatr J 15 1979 91 95
39. Wayne AS, Tan CT, Arceci RJ, et al. 2-Chlorodeoxyadenosine for refractory histiocytosis syndromes: Preliminary experience in pediatrics. Proc Histiocyte Society 10th Annual Meeting, 1994
40. C.L. Willman Detection of clonal histiocytes in Langerhans cell histiocytosis: Biology and clinical significance Br J Cancer 70 suppl XXIII 1994 S29 S33